  0 Table of Contents |
  1 Example Home |
| 2 Therapy Recommendation |
 3 Artifacts Summary |
 3.1 Cancer diagnosis |
| 3.2 Discharge-Summary-Reference |
| 3.3 Episode Of care |
| 3.4 MedicationStatement |
| 3.5 Observation Disease Status |
| 3.6 Observation-EBV |
| 3.7 Observation-ECOG |
| 3.8 Observation-ERS |
| 3.9 Observation-HER2 |
| 3.10 Observation-HPV |
| 3.11 Observation-Krankheitsverlauf |
| 3.12 Observation-PDL |
| 3.13 Observation-PRS |
| 3.14 Observation-Subtype |
| 3.15 Observation-UICC-TNM |
| 3.16 Patient |
| 3.17 Radiation procedure |
| 3.18 Surgery procedure |
| 3.19 Genetic Variant |
| 3.20 HRD Score |
| 3.21 ImportantVariantList |
| 3.22 Observation-MSI |
| 3.23 Tumor Mutation Burden |
| 3.24 VituReport |
| 3.25 Medication recommendation |
| 3.26 Therapy recommendation |
| 3.27 Therapy recommendation plan |
| 3.28 Therapy Recommendation Reason |
| 3.29 Basic Therapy recommendation |
| 3.30 Combination Therapy recommendation |
| 3.31 medication-request-abacavir |
| 3.32 medication-request-flot |
| 3.33 Recommendation against |
| 3.34 Therapy recommendation plan example |
| 3.35 Therapy recommendation reason against treatment |
| 3.36 Therapy recommendation reason example |
| 3.37 Therapy recommendation reason example with multiple reasons |
| 3.38 Trial recommendation |
| 3.39 Case Registration Composition |
| 3.40 List of important variants |
| 3.41 Task |
| 3.42 Tumor Board Case Review |
| 3.43 VITUTumorboardCaseReview |
| 3.44 Medication |
| 3.45 Organization |
| 3.46 Practitioner |
| 3.47 PractitionerRole |
| 3.48 Tumor Board Conference |
| 3.49 VITU Conference |
| 3.50 Add Concept to Medication Operation |
| 3.51 Get tumor-board recommendation document |
| 3.52 EncounterDateStart |
| 3.53 MolitEpisodeOfCareExtensionSP |
| 3.54 TaskInput |
| 3.55 Data-Donation-Consent |
| 3.56 Note-Reference |
| 3.57 Other-Document-Reference |
| 3.58 Pathology-Report-Reference |
| 3.59 PotentielleTherapieOption |
| 3.60 Related Publication Artifact |
| 3.61 VituSpecimen |
| 3.62 VITUTumorboardEmpfehlung |
| 3.63 VituTumorboardEmpfehlungPDFExport |
| 3.64 AssociatedReport |
| 3.65 Evidence of recommendation Extension |
| 3.66 Filename |
| 3.67 Literature as evidence |
| 3.68 Medication recommendation |
| 3.69 Patientenfall in VITU |
| 3.70 Priority of recommendation |
| 3.71 ReasonCancelled |
| 3.72 Recommendation Category |
| 3.73 Treatment context |
| 3.74 Tumor-Morphologie-Subtyp |
| 3.75 Biomarkers |
| 3.76 ConsentMolitDsVS |
| 3.77 DKTK Evidence Levels |
| 3.78 DNA Change Type |
| 3.79 ECOG |
| 3.80 FunctionalClasseVS |
| 3.81 Gesamtbeurteilung Tumor Status |
| 3.82 High|Medium|Low |
| 3.83 Identifier-Types |
| 3.84 MaterialTypenVS |
| 3.85 Medications and Protocols with ATC Codes |
| 3.86 MSIAnswerCodes in VITU |
| 3.87 Note-Types |
| 3.88 Recommendation category |
| 3.89 Recommendation-Status-Types |
| 3.90 Recommendation-Status-Types |
| 3.91 RequestGroupActionCodeVS |
| 3.92 Simplified ValueSet for UICC Stage Codes |
| 3.93 SubstanceOrProtocolVS |
| 3.94 Therapy Recommendation Types |
| 3.95 Therapy-point-in-time |
| 3.96 TNM-M |
| 3.97 TNM-N |
| 3.98 TNM-T |
| 3.99 TNM-Types |
| 3.100 Treatment context |
| 3.101 Tumorboard Abbruchgrund |
| 3.102 Tumortype |
| 3.103 UICC cancer stage |
| 3.104 ValueSet der Therapiearten |
| 3.105 ValueSet for HGNC Genes |
| 3.106 ValueSet for PractitionerRole.speciality |
| 3.107 ValueSet für Tumorarten |
| 3.108 VariantEffectVS |
| 3.109 VITU Organizations |
| 3.110 Vitu Workinglist ValueSet |
| 3.111 CodeSystem Consent ZvPM |
| 3.112 CodeSystem TNM Klassifizierung |
| 3.113 Effekt der Variante |
| 3.114 Materialtypen |
| 3.115 SubstanceOrProtocol |
| 3.116 Tags für VITU-Ressourcen |
| 3.117 Tumorarten |
| 3.118 Tumorboard Abbruchgrund |
| 3.119 UICC-Stage-Klassifikation |
| 3.120 VITU Arbeitslistenstatus CodeSystem |
| 3.121 Vitu Identifier Types |
| 3.122 VITU-Evidence Levels |
| 3.123 VITU-Gesamtbeurteilung Tumorstatus (nach ADTGEKID) |
| 3.124 VITU-Notizarten |
| 3.125 VITU-Organisationen |
| 3.126 VituCompositionDocumentType |
| 3.127 VITUTask |
| 3.128 Arzt |
| 3.129 Arztbrief |
| 3.130 Arztbriefreferenz |
| 3.131 ArztRolle |
| 3.132 Beispielpatient |
| 3.133 Beispieltask |
| 3.134 CEGAT |
| 3.135 EBV |
| 3.136 ECOG |
| 3.137 Erkrankungszustand |
| 3.138 ERS |
| 3.139 ExportPdfBundle |
| 3.140 Genetic Variant CNV, BRCA2 |
| 3.141 Genetic Variant SNV, EGFR |
| 3.142 HER2 |
| 3.143 HPV |
| 3.144 HRDObservationExample |
| 3.145 Krankheitsverlauf |
| 3.146 Krebssubtyp |
| 3.147 Medikation |
| 3.148 MolecularReport |
| 3.149 MSI |
| 3.150 MTB Anmeldeformular |
| 3.151 Notiz |
| 3.152 Notizreferenz |
| 3.153 Operation |
| 3.154 OtherKonferenz |
| 3.155 Pankreaskrebsdiagnose |
| 3.156 Pathobefund |
| 3.157 Pathobefundreferenz |
| 3.158 PDL |
| 3.159 PotentielleTherapieOptionExample |
| 3.160 PRS |
| 3.161 Publikationsreferenz |
| 3.162 questionnaire-response-example |
| 3.163 research-subject-example |
| 3.164 SLK |
| 3.165 SonstigesDokument |
| 3.166 SonstigesDokumentreferenz |
| 3.167 Strahlentherapie |
| 3.168 SystemischeTherapie |
| 3.169 TempDokument |
| 3.170 Testpatient |
| 3.171 TMBFall |
| 3.172 TMBKonferenz |
| 3.173 TMBObservationExample |
| 3.174 TumorBoardEmpfehlung |
| 3.175 Tumorerkrankung |
| 3.176 UICCTNM |
| 3.177 VITU Sample |
| 3.178 VITUConsentDatenspende |
| 3.179 VITUConsentDatenspendeV2 |
 3.180 VituTumorboardEmpfehlungPDFExportExample |
|
Propose a change